|
Monday 31 May |
|
Opening of the workshop |
|||
|
Welcoming talk: Coping with viral Hepatitis in Israel – A historic perspective |
D. Shouval |
N.A. |
|
|
|
|||
|
Session 1: Hepatic damage in HIV infection |
|||
|
Invited lecture: Aging liver in HIV |
M-L. Vachon |
|
|
|
Invited lecture: Non-cirrhotic portal hypertension in HIV |
V. Soriano |
|
|
|
LPS, immune activation and liver disease in HIV-HBV co-infection |
M. Crane |
N.A. |
|
|
The role of HBsAG and fluconazole in nevirapine related hepatotoxicity in sub-Saharan Africa |
L. Katsidzira |
|
|
|
Plasma levels of bacterial DNA in HIV and HIV/HCV co-infected patients |
S. Novati |
N.A. |
|
|
|
|||
|
Session 2: Management of Liver fibrosis and End-stage liver disease |
|||
|
Invited lecture: Hepatocellular carcinoma in HIV-Infected Persons – A growing complication of co-infection with HCV or HBV |
N. Bräu |
|
|
|
Independent predictors of Fib4 rise among HIV-infected patients with or without HBV/HCV co-infection in the ICONA foundation study |
M. Puoti |
N.A. |
|
|
Continental differences of Hepatocellular carcinoma (HCC) in HIV-infected patients. A pilot study in North and South America and Europe |
E. Page |
N.A. |
|
|
Clinical Case presentation --- HCC related |
R. Bruno |
|
|
|
|
|||
|
|
|||
|
|
|||
|
|
a Medical Education company
